An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

References

• DavidovEBreitscheidelLClouthJReipsMHappichMDiabetic retinopathy and health-related quality of lifeGraefes Arch Clin Exp Ophthalmol2009247226727218925408
   PubMed Web of Science ®Google Scholar
• HariprasadSMMielerWFGrassiMGreenJLJagerRDMillerLVision-related quality of life in patients with diabetic macular oedemaBr J Ophthalmol2008921899217584999
   PubMed Web of Science ®Google Scholar
• LoftusJVSultanMBPleilAMChanges in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or shamInvest Ophthalmol Vis Sci201152107498750521896838
   PubMed Web of Science ®Google Scholar
• ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ2004821184485115640920
   PubMed Web of Science ®Google Scholar
• ScanlonPHMartinMLBaileyCJohnsonEHykinPKeightleySReported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathyDiabet Med2006231606616409567
   PubMed Web of Science ®Google Scholar
• SharmaSOliver-FernandezALiuWBuchholzPWaltJThe impact of diabetic retinopathy on health-related quality of lifeCurr Opin Ophthalmol200516315515915870571
   PubMedGoogle Scholar
• TranosPGTopouzisFStangosNTEffect of laser photocoagulation treatment for diabetic macular oedema on patient’s vision-related quality of lifeCurr Eye Res2004291414915370366
   PubMed Web of Science ®Google Scholar
• International Diabetes FederationIDF Diabetes Atlas5th ed2011 Available from: http://www.idf.org/diabetesatlasAccessed September 4, 2012
   Google Scholar
• FaragYMKGaballaMRDiabesity: an overview of a rising epidemicNephrol Dial Transplant2011261283521045078
   PubMed Web of Science ®Google Scholar
• KolbHMandrup-PoulsenTThe global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammationDiabetologia2010531102019890624
   PubMed Web of Science ®Google Scholar
• KleinRKnudtsonMDLeeKEGangnonRKleinBEThe Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetesOphthalmology2008115111859186819068374
   PubMed Web of Science ®Google Scholar
• RubinoARousculpMDDavisKWangJGirachADiagnosed diabetic retinopathy in France, Italy, Spain, and the United KingdomPrim Care Diabetes200712758018632023
   PubMedGoogle Scholar
• WongTYCheungNTayWTPrevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye StudyOphthalmology2008115111869187518584872
   PubMed Web of Science ®Google Scholar
• ElmanMJAielloLPBeckRWRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology2010117610641077.e3520427088
   PubMed Web of Science ®Google Scholar
• MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care201033112399240520980427
   PubMed Web of Science ®Google Scholar
• MichaelidesMKainesAHamiltonRDA prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2Ophthalmology2010117610781086.e220416952
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMHeierJSPrimary end point (six months) results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) studyOphthalmology20091161121752181.e119700194
   PubMed Web of Science ®Google Scholar
• SultanMBZhouDLoftusJDombiTIceKSA phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edemaOphthalmology201111861107111821529957
   PubMed Web of Science ®Google Scholar
• KliffenMSharmaHSMooyCMKerkvlietSde JongPTIncreased expression of angiogenic growth factors in age-related maculopathyBr J Ophthalmol19978121541629059252
   PubMed Web of Science ®Google Scholar
• AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol199411844454507943121
   PubMed Web of Science ®Google Scholar
• AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med199433122148014877526212
   PubMed Web of Science ®Google Scholar
• FunatsuHYamashitaHNomaHMimuraTYamashitaTHoriSIncreased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edemaAm J Ophthalmol20021331707711755841
   PubMed Web of Science ®Google Scholar
• CunninghamETJrAdamisAPAltaweelMA phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaOphthalmology2005112101747175716154196
   PubMed Web of Science ®Google Scholar
• NicholsonBPSchachatAPA review of clinical trials of anti-VEGF agents for diabetic retinopathyGraefes Arch Clin Exp Ophthalmol2010248791593020174816
   PubMed Web of Science ®Google Scholar
• QuerquesGBuxAVFuscoARIaculliCDelle NociNPegaptanib sodium versus pegaptanib sodium combined with macular laser photocoagulation or laser alone for diabetic macular edemaJ Ophthalmol2009200967217820339449
   PubMed Web of Science ®Google Scholar
• QuerquesGBuxAVMartinelliDIaculliCNociNDIntravitreal pegaptanib sodium (Macugen) for diabetic macular oedemaActa Ophthalmol200987662363019678810
   PubMed Web of Science ®Google Scholar
• AdamisAPAltaweelMBresslerNMChanges in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individualsOphthalmology20061131232816343627
   PubMed Web of Science ®Google Scholar
• PacellaELa TorreGImpallaraDEfficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-upClin Ter20131642e121e12623698213
   PubMed Web of Science ®Google Scholar